MarketMicrohomology-mediated end joining
Company Profile

Microhomology-mediated end joining

Microhomology-mediated end joining (MMEJ), also known as alternative nonhomologous end-joining (Alt-NHEJ) is one of the pathways for repairing double-strand breaks in DNA. As reviewed by McVey and Lee, the foremost distinguishing property of MMEJ is the use of microhomologous sequences during the alignment of broken ends before joining, thereby resulting in deletions flanking the original break. MMEJ is frequently associated with chromosome abnormalities such as deletions, translocations, inversions and other complex rearrangements.

Cell cycle regulation
MMEJ repair is low in G0/G1 phase but is increased during S-phase and G2 phase of the cell cycle. In contrast, NHEJ operates throughout the cell cycle, and homologous recombination (HR) operates only in late S and G2. ==Double strand break repair pathway choice==
Double strand break repair pathway choice
The choice of which pathway is used for double strand break repair is complex. In most cases, MMEJ accounts for a minor proportion (10%) of double strand break repair, most likely in cases where the double strand break is resected but a sister chromatid is not available for homologous recombination. ==Genes required==
Genes required
A biochemical assay system shows that at least 6 genes are required for microhomology-mediated end joining: FEN1, Ligase III, MRE11, NBS1, PARP1 and XRCC1. All six of these genes are up-regulated in one or more cancers. In humans, DNA polymerase theta, encoded by the POLQ gene, plays a central role in microhomology-mediated end joining. ==In cancer==
In cancer
Approximately half of all ovarian cancers are deficient in homologous recombination (HR). These HR-deficient tumors upregulate polymerase theta (POLQ), resulting in an increase in MMEJ. These tumors are hyper-reliant upon MMEJ, so that knockdown of polymerase theta results in substantial lethality. In most cell types, MMEJ makes a minor contribution to double strand break repair. The hyper-reliance of HR-deficient tumors upon MMEJ may represent a possible drug target for cancer treatment. MMEJ always involves insertions or deletions, so that it is a mutagenic pathway. Cells with increased MMEJ may have higher genomic instability and a predisposition towards cancer development, although this has not been demonstrated directly. ==In a crustacean==
In a crustacean
Penaeus monodon is a marine crustacean widely consumed for its nutritional value. Repair of double-strand breaks in this organism can occur by HRR, but NHEJ is undetectable. While HRR appears to be the major double-strand break repair pathway, MMEJ was also found to play a significant role in repair of DNA double-strand breaks. == References ==
General references
• MMEJ repair of double-strand breaks (director's cut): deleted sequences and alternative endings • DNA double strand break repair in human bladder cancer is error prone and involves microhomology-associated end-joining • Distinctive differences in DNA double-strand break repair between normal urothelial and urothelial carcinoma cells
tickerdossier.comtickerdossier.substack.com